Skip to main content

Table 1 Clinical and sociodemographic data (N = 242)

From: Adherence evaluation of endocrine treatment in breast cancer: methodological aspects

 

Frequency (%)

Age

Median (SD)

65.00 y (8.3y)

 

Range

40-84y

Marital status

Single

18 (8.4%)

 

Partnership, marriage

135 (63.1%)

 

Divorced, separated

28 (13.1%)

 

Widowed

33 (15.4%)

Employment status

Full-time

16 (7.5%)

 

Part-time

16 (7.5%)

 

Unemployed

5 (2.1%)

 

Homemaker

31 (14.5%)

 

Retired

142 (66.4%)

 

Other

4 (1.6%)

Histological classification

Invasive

226 (93.4%)

 

In situ

15 (6.2%)

 

Missing

1 (0.4%)

Grading

Grade I

35 (14.5%)

 

Grade II

176 (72.7%)

 

Grade III

10 (4.1%)

 

Unknown

21 (8.7%)

Duration of adjuvant endocrine therapy (months)

Median (SD)

26.7 (19.1) mo.

 

Range

0.7- 89.5 mo.

Primary surgical treatment

Breast-conserving procedure

155 (65.7%)

 

Mastectomy

81 (34.3%)

 

Reconstruction

43 (18.2%)

Chemotherapy

 

41 (16.9%)

Radiotherapy

 

169 (71.3%)